Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Akorn Inc (NASDAQ:AKRX)

18.60
Delayed Data
As of Dec 09
 +0.20 / +1.09%
Today’s Change
17.57
Today|||52-Week Range
39.46
-50.15%
Year-to-Date
Why Shares of Drug Maker Akorn Are a Buy After Losing 50% in 2016
Dec 08 / TheStreet.com - Paid Partner Content
3 Reasons Akorn Inc. Stock Could Rise
Dec 02 / MotleyFool.com - Paid Partner Content
3 Reasons Akorn Inc. Could Fall
Dec 08 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close18.40
Today’s open18.58
Day’s range18.36 - 18.81
Volume1,897,884
Average volume (3 months)1,433,317
Market cap$2.3B
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+260.41%
Earnings growth (this year)+10.65%
Earnings growth (next 5 years)+9.40%
Revenue growth (last year)+66.10%
P/E ratio12.7
Price/Sales4.76
Price/Book3.57

Competitors

 Today’s
change
Today’s
% change
HZNPHorizon Pharma PLC-0.20-1.33%
IRWDIronwood Pharmaceuti...+0.35+2.35%
MDCOMedicines Co+2.03+6.19%
LGNDLigand Pharmaceutica...+0.85+0.82%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateMarch 7, 2017
EPS forecast (this quarter)$0.58
Annual revenue (last year)$985.1M
Annual profit (last year)$150.8M
Net profit margin15.31%

Profile

Sector
Distribution Services
Industry
Medical Distributors
Chief Executive Officer
Raj Rai
Chief Operating Officer
Bruce Kutinsky
Corporate headquarters
Lake Forest, Illinois

Forecasts


Search for Jobs